Objective
One of the most important challenges that drug development researchers face today is the low aqueous solubility of the active pharmaceutical ingredients (APIs). Most of the drug molecules under investigation exhibit poor water solubility and additional efforts are required to improve their solubility feature. Thus, the development of amorphous drugs is the most effective way how to improve the bioavailability of the APIs, and huge amount of effort is directed towards this smart approach. The aim of this project is to develop a reliable and universally applicable dynamic physio-chemical procedure for the description of the interconnection between the microscopic and macroscopic description of the triggered phase transformation a task that would lay fundamental principles for the prediction of the macroscopic manifestation of the sub & near-Tg crystal growth in the class III amorphous drugs. This proposal is SMART as this is first case of designing the unique green, dynamic and advanced molecular crystal nucleation near interface. In addition, the SMART project also aims to develop the combined experimental and mathematical procedural approach for fast, reliable, and accurate projections of the sub & near-Tg amorphous-to-crystalline dynamic transformation in amorphous APIs.
Keywords
Programme(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Funding Scheme
HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European FellowshipsCoordinator
590 53 Ulrika
Sweden